88 related articles for article (PubMed ID: 23886095)
1. [Thrichosanthin enhances cisplatin-induced laryngocarcinoma apoptosis through inhibiting transcription factor nuclear factor κB].
Zhang D; Lu LM; Chen B; Li Q; Zhou J; Tao L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Apr; 48(4):322-8. PubMed ID: 23886095
[TBL] [Abstract][Full Text] [Related]
2. Low concentrations of trichosanthin induce apoptosis and cell cycle arrest via c-Jun N-terminal protein kinase/mitogen-activated protein kinase activation.
Zhang D; Chen B; Zhou J; Zhou L; Li Q; Liu F; Chou KY; Tao L; Lu LM
Mol Med Rep; 2015 Jan; 11(1):349-56. PubMed ID: 25351837
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
Dong X; Liu F; Li M
Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone enhances trichosanthin-induced apoptosis in the HepG2 hepatoma cell line.
Li M; Chen F; Liu CP; Li DM; Li X; Wang C; Li JC
Life Sci; 2010 Jan; 86(1-2):10-6. PubMed ID: 19891978
[TBL] [Abstract][Full Text] [Related]
5. TSR2 Induces laryngeal cancer cell apoptosis through inhibiting NF-κB signaling pathway.
He HJ; Bing H; Liu G
Laryngoscope; 2018 Apr; 128(4):E130-E134. PubMed ID: 29280495
[TBL] [Abstract][Full Text] [Related]
6. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.
Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M
Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562
[TBL] [Abstract][Full Text] [Related]
7. Thermosensitization and induction of apoptosis or cell-cycle arrest via the MAPK cascade by parthenolide, an NF-κB inhibitor, in human prostate cancer androgen-independent cell lines.
Hayashi S; Koshiba K; Hatashita M; Sato T; Jujo Y; Suzuki R; Tanaka Y; Shioura H
Int J Mol Med; 2011 Dec; 28(6):1033-42. PubMed ID: 21805026
[TBL] [Abstract][Full Text] [Related]
8. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells.
Oiso S; Ikeda R; Nakamura K; Takeda Y; Akiyama S; Kariyazono H
Oncol Rep; 2012 Jul; 28(1):27-32. PubMed ID: 22562377
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
Liu T; Peng H; Zhang M; Deng Y; Wu Z
Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353
[TBL] [Abstract][Full Text] [Related]
10. Sesquiterpene lactone parthenolide markedly enhances sensitivity of human A549 cells to low-dose oxaliplatin via inhibition of NF-kappaB activation and induction of apoptosis.
Fang LJ; Shao XT; Wang S; Lu GH; Xu T; Zhou JY
Planta Med; 2010 Feb; 76(3):258-64. PubMed ID: 19774508
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production.
Poma P; Notarbartolo M; Labbozzetta M; Sanguedolce R; Alaimo A; Carina V; Maurici A; Cusimano A; Cervello M; D'Alessandro N
Int J Oncol; 2006 Apr; 28(4):923-30. PubMed ID: 16525642
[TBL] [Abstract][Full Text] [Related]
12. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
14. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
He HN; Wang X; Zheng XL; Sun H; Shi XW; Zhong YJ; Huang B; Yang L; Li JK; Liao LC; Zhang L; Hu LN; Lin Y
Cancer Lett; 2010 Sep; 295(1):38-43. PubMed ID: 20207071
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
[TBL] [Abstract][Full Text] [Related]
16. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL
Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of pyrrolidine dithiocarbamate and cisplatin in human cervical carcinoma.
Zheng X; Lv J; Shen Q; Chen Y; Zhou Q; Zhang W; Zhu X
Reprod Sci; 2014 Oct; 21(10):1319-25. PubMed ID: 24594834
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effects of intervention of the TNFa/NF-kappaB signaling pathway activation on hepatoma cell proliferation].
Gu X; Yao M; Wang S; Shi Y; Dong Z; Qiu L; Yao D
Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):434-9. PubMed ID: 25203707
[TBL] [Abstract][Full Text] [Related]
19. Activation of unfolded protein response protects osteosarcoma cells from cisplatin-induced apoptosis through NF-κB pathway.
Yan M; Ni J; Song D; Ding M; Huang J
Int J Clin Exp Pathol; 2015; 8(9):10204-15. PubMed ID: 26617729
[TBL] [Abstract][Full Text] [Related]
20. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
Schön M; Wienrich BG; Kneitz S; Sennefelder H; Amschler K; Vöhringer V; Weber O; Stiewe T; Ziegelbauer K; Schön MP
J Natl Cancer Inst; 2008 Jun; 100(12):862-75. PubMed ID: 18544741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
